Display Options:
Total: 1496
Small molecule
Approved
OTHER
INJECTION
Unknown
Diagnostic agent
Small molecule
Approved
IMMUNE SYSTEM; NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER; PEDIATRICS
ORAL
Alopecia; Child Development Disorders, Pervasive; Glioblastoma; Premature Birth; Psychotic Disorders; Abortion, Spontaneous; Anemia, Sickle Cell; Breast Neoplasms; HIV Infections; Hyperemesis Gravidarum; Intervertebral Disc Displacement; Low Back Pain; Marijuana Abuse; Mucositis; Multiple Sclerosis; Neoplasms; Paget Disease, Extramammary; Peripheral Nervous System Diseases; Postoperative Complications; Prostatic Neoplasms, Castration-Resistant; Rotator Cuff Injuries; Sleep Wake Disorders; Substance-Related Disorders; Substance Withdrawal Syndrome; Tinnitus; Tobacco Use Disorder; Urinary Bladder Neoplasms; Wounds and Injuries; Alcohol Drinking; Alcoholism; Anxiety; Azoospermia; Brain Injuries; Carpal Tunnel Syndrome; Chronic Pain; Cystitis, Interstitial; Delirium; Dementia; Depressive Disorder; Diabetic Neuropathies; Dyspepsia; Epilepsies, Partial; Fibromyalgia; Head and Neck Neoplasms; Herpes Zoster; Hot Flashes; Intervertebral Disc Degeneration; Liver Cirrhosis; Lung Diseases; Neuralgia; Opioid-Related Disorders; Oropharyngeal Neoplasms; Pain; Pelvic Organ Prolapse; Postoperative Nausea and Vomiting; Pruritus; Schizophrenia; Scoliosis; Sleep Initiation and Maintenance Disorders; Tremor; Vomiting; Epilepsy; Neuralgia, Postherpetic; Restless Legs Syndrome; Seizures
Voltage-gated calcium channel modulator
Unknown
Approved
OTHER
INJECTION
Breast Neoplasms; Pancreatitis; Hemorrhage
Plasma kallikrein inhibitor
Small molecule
Approved
OTHER
TOPICAL
Carcinoma, Squamous Cell; Scleroderma, Localized; Vitiligo; Acne Vulgaris; Dermatitis, Atopic; Eczema; Keratosis, Actinic; Radiodermatitis; Skin Diseases; Psoriasis
Vitamin D receptor agonist
Small molecule
Approved
CARDIOVASCULAR; DIABETES DRUGS & ENDOCRINOLOGY; OTHER
ORAL
Cholangitis, Sclerosing; Alcoholism; Burns; Diabetic Nephropathies; HIV Infections; Huntington Disease; Inflammatory Bowel Diseases; Metabolic Syndrome; Multiple Myeloma; Non-alcoholic Fatty Liver Disease; Obesity; Atherosclerosis; Coronary Disease; Diabetic Retinopathy; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemias; Hyperlipoproteinemia Type III; Hypertension; Hypertriglyceridemia; Lipid Metabolism Disorders; Lipodystrophy; Liver Cirrhosis, Biliary; Metabolic Diseases; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dyslipidemias; Hypercholesterolemia; Hypothyroidism
Peroxisome proliferator-activated receptor alpha agonist
Small molecule
Approved
OTHER
ORAL
Bipolar Disorder; Anemia; Epilepsy; Seizures
Glutamate [NMDA] receptor antagonist
Small molecule
Approved
DIABETES DRUGS & ENDOCRINOLOGY; OTHER; PEDIATRICS
ORAL
Acidosis, Lactic; Acquired Immunodeficiency Syndrome; AIDS-Associated Nephropathy; AIDS Dementia Complex; HIV Infections; Virus Diseases
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
Enzyme
Approved
OTHER
UNKNOWN
Leukemia, Myeloid, Acute; Granuloma, Lethal Midline; Leukemia; Leukemia, Biphenotypic, Acute; Leukemia, Lymphoid; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Asparagine hydrolytic enzyme
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Fasting; HIV Infections; Lecithin Cholesterol Acyltransferase Deficiency; Mental Disorders; Alcoholism; Cocaine-Related Disorders; Cognitive Dysfunction; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neuralgia, Postherpetic; Neurofibromatosis 1; Opioid-Related Disorders; Substance-Related Disorders; Anxiety; Dementia; Epilepsy, Absence; Feeding and Eating Disorders; Mood Disorders; Obesity; Pain; Peripheral Nervous System Diseases; Schizophrenia; Bipolar Disorder; Depressive Disorder; Epilepsies, Partial; Epilepsy; Epilepsy, Tonic-Clonic; Lennox Gastaut Syndrome; Seizures
Sodium channel alpha subunit blocker
Enzyme
Approved
OTHER
INJECTION
Anemia; Gaucher Disease; Thrombocytopenia
Glucocerebroside hydrolytic enzyme
Enzyme
Approved
OTHER
UNKNOWN
Leukemia, Biphenotypic, Acute; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Leukemia; Leukemia, Basophilic, Acute; Leukemia, Erythroblastic, Acute; Leukemia, Megakaryoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; Lymphoma; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Myeloproliferative Disorders; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma, Myeloid; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Asparagine hydrolytic enzyme
Small molecule
Approved
DERMATOLOGY; DIABETES DRUGS & ENDOCRINOLOGY; OTHER; UROLOGY AND KIDNEY
INJECTION; ORAL; TOPICAL
Hematologic Neoplasms; Anemia, Aplastic; Anemia, Sickle Cell; Graft vs Host Disease; Lichen Planus, Oral; Thalassemia; Conjunctivitis, Allergic; Keratoconjunctivitis; Delayed Graft Function; Dermatitis, Atopic; Eczema; Immune System Diseases; Kidney Transplantation; Liver Transplantation
FK506-binding protein 1A inhibitor
Small molecule
Approved
OTHER
ORAL
Panic Disorder; Obsessive-Compulsive Disorder
Serotonin transporter inhibitor
Small molecule
Approved
OTHER
OPHTHALMIC
Dry Eye Syndromes; Eye Diseases
Glucocorticoid receptor agonist
Small molecule
Approved
IMMUNE SYSTEM; OTHER
ORAL
Multiple Sclerosis; Herpes Simplex; Meniere Disease; Autoimmune Diseases; Eye Infections; Herpes Genitalis; Herpes Labialis; Herpes Zoster; Virus Diseases
Human herpesvirus 1 DNA polymerase inhibitor
Small molecule
Approved
GASTROINTESTINAL; OTHER; RESPIRATORY
INHALATION; NASAL; ORAL; RECTAL
Cholangitis, Sclerosing; Anosmia; Aspergillosis, Allergic Bronchopulmonary; Breast Neoplasms; Bronchiolitis Obliterans; Diarrhea; Esophageal Stenosis; Hepatitis, Autoimmune; Hypersensitivity; Inflammatory Bowel Diseases; Lung Neoplasms; Malnutrition; Melanoma; Multiple Myeloma; Nasal Polyps; Proctitis; Radiation Pneumonitis; Respiratory Distress Syndrome; Status Asthmaticus; Altitude Sickness; Bronchiolitis Obliterans Syndrome; Bronchopulmonary Dysplasia; Colitis, Collagenous; Colitis, Lymphocytic; Colitis, Microscopic; Eosinophilic Esophagitis; Graft vs Host Disease; Liver Cirrhosis, Biliary; Proctocolitis; Respiratory Tract Diseases; Severe Acute Respiratory Syndrome; Sinusitis; Sleep Apnea, Obstructive; Snoring; Asthma; Bronchitis, Chronic; Colitis, Ulcerative; Crohn Disease; Emphysema; Esophageal Diseases; Glomerulonephritis, IGA; Lung Diseases, Obstructive; Nasal Obstruction; Pulmonary Disease, Chronic Obstructive; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal
Glucocorticoid receptor agonist
Small molecule
Approved
OTHER
ORAL
Cardiovascular Diseases; Hypertension
Voltage-gated L-type calcium channel blocker
Small molecule
Approved
OTHER
ORAL
Fallopian Tube Neoplasms; Gynecomastia; Ovarian Neoplasms; Peritoneal Neoplasms; Puberty, Precocious; Salivary Gland Neoplasms; Urinary Bladder Neoplasms; Breast Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Severe Acute Respiratory Syndrome; Carcinoma; Neoplasms
Androgen Receptor antagonist
Small molecule
Approved
CARDIOVASCULAR; IMMUNE SYSTEM; OTHER
ORAL
Arthritis, Rheumatoid; beta-Thalassemia; Carcinoma, Renal Cell; DiGeorge Syndrome; Glioblastoma; Gliosarcoma; Hypertension; Lecithin Cholesterol Acyltransferase Deficiency; Leukemia, Lymphoid; Leukemia, Myeloid; Neoplasms, Neuroepithelial; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Amyotrophic Lateral Sclerosis; Anemia, Aplastic; Anemia, Diamond-Blackfan; Anemia, Sickle Cell; Autoimmune Diseases; Bronchiolitis Obliterans Syndrome; Burkitt Lymphoma; Cardiomyopathies; Chemical and Drug Induced Liver Injury; Crohn Disease; Epidermolysis Bullosa; Fanconi Anemia; Gout; Granuloma, Lethal Midline; Graves Disease; Hematologic Diseases; Hematologic Neoplasms; Hemoglobinuria; Hepatitis, Alcoholic; Histiocytosis, Langerhans-Cell; HIV Infections; Hyperlipoproteinemia Type I; IgA Vasculitis; Immunoblastic Lymphadenopathy; Immunologic Deficiency Syndromes; Kidney Neoplasms; Leukemia, Large Granular Lymphocytic; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Mast-Cell; Leukemia, Myelomonocytic, Chronic; Leukemia, Myelomonocytic, Juvenile; Leukemia, Prolymphocytic, B-Cell; Leukemia, Prolymphocytic, T-Cell; Liver Diseases; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Peripheral; Macular Degeneration; Melanoma; Multiple Sclerosis; Mycosis Fungoides; Myeloproliferative Disorders; Neoplasms, Plasma Cell; Neuroblastoma; Neuronal Ceroid-Lipofuscinoses; Pemphigoid, Benign Mucous Membrane; Pemphigoid, Bullous; Polycythemia Vera; Primary Myelofibrosis; Psoriasis; Renal Insufficiency, Chronic; Scleroderma, Diffuse; Scleroderma, Limited; Scleroderma, Systemic; Severe Combined Immunodeficiency; Sezary Syndrome; Shwachman-Diamond Syndrome; Sjogren's Syndrome; Vasculitis; Wiskott-Aldrich Syndrome; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Carcinoma, Hepatocellular; Cardiovascular Diseases; Cystitis, Interstitial; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Graft vs Host Disease; Granulomatosis with Polyangiitis; Heart Diseases; Hepatitis C; Hodgkin Disease; Kidney Diseases; Kidney Failure, Chronic; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lung Diseases, Interstitial; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Microscopic Polyangiitis; Multiple Myeloma; Myasthenia Gravis; Myelodysplastic Syndromes; Neoplasms; Nephrotic Syndrome; Neuromyelitis Optica; Pemphigus; Polyradiculopathy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Purpura, Thrombocytopenic, Idiopathic; Red-Cell Aplasia, Pure; Renal Insufficiency; Takayasu Arteritis; Uveitis; Waldenstrom Macroglobulinemia; Delayed Graft Function
Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor
Small molecule
Approved
DIABETES DRUGS & ENDOCRINOLOGY; OTHER
ORAL
Hypotension, Orthostatic; Nesidioblastosis; Obesity; Aging; Kidney Neoplasms; Non-alcoholic Fatty Liver Disease; Atherosclerosis; Coronary Disease; Diabetes, Gestational; Hypercholesterolemia; Hypertension; Metabolic Diseases; Metabolic Syndrome; Diabetes Mellitus; Diabetes Mellitus, Type 2
Maltase-glucoamylase inhibitor
Small molecule
Approved
DERMATOLOGY; OTHER
TOPICAL
Melanosis; Dermatitis, Perioral; Dermatitis, Seborrheic; Acne Vulgaris; Erythema; Rosacea
Unknown
Small molecule
Approved
DIABETES DRUGS & ENDOCRINOLOGY; IMMUNE SYSTEM; OTHER
ORAL
Alzheimer Disease; Glioma; Colorectal Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Paraparesis, Tropical Spastic; Sarcoma, Kaposi; Small Cell Lung Carcinoma; Acquired Immunodeficiency Syndrome; AIDS-Associated Nephropathy; Carcinoma, Hepatocellular; Diarrhea; Liver Cirrhosis; Tuberculosis; Autoimmune Diseases; Hepatitis; Hepatitis B; Hepatitis B, Chronic; HIV Infections; Infections; Inflammation; Virus Diseases
DNA inhibitor
Small molecule
Approved
GASTROINTESTINAL; OTHER
INTRAVENOUS; ORAL
Cystic Fibrosis; Laryngopharyngeal Reflux; Neoplasms; Pain; Endometrial Neoplasms; Eosinophilic Esophagitis; Leukemia, Lymphocytic, Chronic, B-Cell; Premature Birth; Pseudomyxoma Peritonei; Rectal Neoplasms; Uterine Cervical Neoplasms; Breast Neoplasms; Diabetes Mellitus, Type 1; Esophagitis, Peptic; Gastritis; Gout; Helicobacter Infections; Idiopathic Pulmonary Fibrosis; Lymphoma; Osteoarthritis; Duodenal Ulcer; Gastroesophageal Reflux; Heartburn; Peptic Ulcer; Stomach Ulcer
Potassium-transporting ATPase inhibitor
Small molecule
Approved
OTHER
INJECTION
Unknown
Diagnostic agent
Small molecule
Approved
OTHER
INJECTION
Unknown
Diagnostic agent
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Breast Neoplasms; Neoplasms; Schizophrenia; Stress Disorders, Post-Traumatic; Alzheimer Disease; Atrial Fibrillation; Bipolar Disorder; Cerebellar Ataxia; Child Development Disorders, Pervasive; Depressive Disorder; Depressive Disorder, Major; Melanoma; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Muscular Atrophy, Spinal; Obsessive-Compulsive Disorder; Peripheral Nervous System Diseases; Spinal Cord Injuries; Huntington Disease; Multiple System Atrophy; Spinal Cord Diseases; Spinocerebellar Ataxias; Supranuclear Palsy, Progressive; Amyotrophic Lateral Sclerosis
Sodium channel alpha subunit blocker
Small molecule
Approved
OTHER
ORAL
Angina, Stable; Arthritis, Rheumatoid; Glioblastoma; Vascular Diseases; Breast Neoplasms; Cardiomyopathies; Cocaine-Related Disorders; Epilepsy; Esophageal and Gastric Varices; Hypertension, Pulmonary; Hypoglycemia; Kidney Diseases; Neoplasms; Prostatic Neoplasms, Castration-Resistant; Stress Disorders, Post-Traumatic; Atherosclerosis; Atrial Fibrillation; Coronary Disease; Diabetes Mellitus, Type 2; Essential Hypertension; Hematologic Neoplasms; Hypercholesterolemia; Hypertension, Portal; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Multiple Myeloma; Renal Insufficiency, Chronic; Cardiovascular Diseases; Heart Failure; Hypertension; Myocardial Infarction; Ventricular Dysfunction, Left
Adrenergic receptor alpha-1 antagonist
Small molecule
Approved
CARDIOVASCULAR; OTHER
INJECTION
Unknown
HERG blocker
Small molecule
Approved
DIABETES DRUGS & ENDOCRINOLOGY; OTHER
INJECTION
Chordoma; Fanconi Anemia; Kidney Neoplasms; Leukemia, Myeloid, Acute; Liver Neoplasms; Mesothelioma; Myeloproliferative Disorders; Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms, Plasma Cell; Neuroblastoma; Retinoblastoma; Breast Neoplasms; Central Nervous System Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms; Hodgkin Disease; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Peritoneal Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Sarcoma; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Carcinoma; Hepatoblastoma; Lung Neoplasms; Multiple Myeloma; Peripheral Nervous System Diseases; Trigeminal Neuralgia; Head and Neck Neoplasms; Ovarian Neoplasms; Xerostomia
Reactive metabolite scavenging agent
Small molecule
Approved
DIABETES DRUGS & ENDOCRINOLOGY; OTHER
ORAL
Atherosclerosis; Coronary Disease; Hypercholesterolemia; Hypertension; Diabetes Mellitus; Diabetes Mellitus, Type 2
Sulfonylurea receptor 1, Kir6.2 blocker
Small molecule
Approved
CANCER; OTHER
ORAL
Aging; Breast Diseases; Endometrial Neoplasms; Hypertension; Kallmann Syndrome; Anovulation; Breast Neoplasms, Male; Carcinoma; Endometriosis; Fibrous Dysplasia, Polyostotic; Hypertension, Pulmonary; Hypogonadism; Hypopituitarism; Metabolic Syndrome; Puberty, Precocious; Triple Negative Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Gynecomastia; Klinefelter Syndrome; Ovarian Neoplasms; Breast Neoplasms; Neoplasms
Cytochrome P450 19A1 inhibitor
Small molecule
Approved
OTHER
INTRAMUSCULAR; ORAL
Dyskinesia, Drug-Induced; Lecithin Cholesterol Acyltransferase Deficiency; Mood Disorders; Weight Loss; Amyotrophic Lateral Sclerosis; Anorexia Nervosa; Autistic Disorder; Delirium; Opioid-Related Disorders; Vomiting; Alcoholism; Anorexia; Anxiety; Borderline Personality Disorder; Dementia; Depressive Disorder; Depressive Disorder, Treatment-Resistant; Developmental Disabilities; Feeding and Eating Disorders; Gambling; Genital Neoplasms, Female; Huntington Disease; Intellectual Disability; Nausea; Neoplasms; Postoperative Nausea and Vomiting; Testicular Neoplasms; Weight Gain; Bipolar Disorder; Depressive Disorder, Major; Mental Disorders; Psychomotor Agitation; Psychotic Disorders; Schizophrenia
D2-like dopamine receptor antagonist
Small molecule
Approved
OTHER
ORAL
Prostatic Neoplasms, Castration-Resistant; Neoplasms; Prostatic Neoplasms
Androgen Receptor antagonist
Small molecule
Approved
IMMUNE SYSTEM; OTHER; PEDIATRICS
ORAL
Amyotrophic Lateral Sclerosis; Anus Neoplasms; Erectile Dysfunction; Glioblastoma; Glioma; Hypertension; Hypertension, Pulmonary; Insulin Resistance; Kidney Diseases; Liver Diseases; Malaria; Neoplasm Metastasis; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Respiratory Distress Syndrome; Tuberculosis; Hepatitis B, Chronic; Mycobacterium avium-intracellulare Infection; Neoplasms; Post-Acute COVID-19 Syndrome; Pregnancy; Sarcoma; Sarcoma, Kaposi; Acquired Immunodeficiency Syndrome; Coronavirus Infections; Hepatitis D; Infections; Influenza, Human; Pneumonia; Severe Acute Respiratory Syndrome; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Virus Diseases
Cytochrome P450 3A inhibitor
Small molecule
Approved
DIABETES DRUGS & ENDOCRINOLOGY; OTHER
ORAL
Postoperative Nausea and Vomiting; Sleep Apnea, Obstructive; Stomach Diseases; Alcoholism; Amphetamine-Related Disorders; Anorexia; Anorexia Nervosa; Cachexia; Cocaine-Related Disorders; Fibromyalgia; Paraganglioma; Substance-Related Disorders; Weight Loss; Anxiety; Child Development Disorders, Pervasive; Dementia; Heroin Dependence; Nausea; Schizophrenia; Depressive Disorder; Depressive Disorder, Major; Sleep Initiation and Maintenance Disorders
Adrenergic receptor alpha-2 antagonist